Skip to content

Author

S. Okovity

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Efficacy and safety of liraglutide and semaglutide in obese children and adolescents: a systematic review

Liraglutide and semaglutide demonstrate significant superiority over placebo in reducing body weight and body mass index in obese children and adolescents and substantiate therapy in pediatric practice with careful assessment of the benefit-risk ratio.

E. A. Kovaleva, O. Nemyatykh, S. Okovity et al. · 0 citations
Open access Oct 2026

Metabolic-associated fatty liver disease and hypertriglyceridemia: cardiovascular risks and current therapeutic approaches

Metabolic-associated fatty liver disease (MAFLD) is a systemic disorder associ-ated with metabolic dysfunction and a high risk of life-threatening conditions, primarily cardiovascular disease. MAFLD is often accompanied by hypertriglyceridemia (HTG), as both conditions share a common pathogenetic mechanism — insulin re...

Y. Khalimov, M. Yezhov, K. Raikhelson et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.